ARTICLE
10 April 2025

Bidi Vapor Appeals FDA's Marketing Denial Order In The 11th Circuit US Court Of Appeals

BI
Buchanan Ingersoll & Rooney PC

Contributor

With 450 attorneys and government relations professionals across 15 offices, Buchanan Ingersoll & Rooney provides progressive legal, business, regulatory and government relations advice to protect, defend and advance our clients’ businesses. We service a wide range of clients, with deep experience in the finance, energy, healthcare and life sciences industries.
On April 2, Bidi Vapor LLC petitioned the Eleventh Circuit U.S. Court of Appeals to overturn a decision by the U.S. Food and Drug Administration (FDA) that denied Bidi's...
United States Food, Drugs, Healthcare, Life Sciences

On April 2, Bidi Vapor LLC petitioned the Eleventh Circuit U.S. Court of Appeals to overturn a decision by the U.S. Food and Drug Administration (FDA) that denied Bidi's Premarket Tobacco Application for marketing disposable e-cigarettes. Bidi's legal counsel, Eric Gotting, contended that the FDA's denial was "arbitrary, capricious, and unlawful," highlighting that the FDA had previously acknowledged that adult smokers of combustible cigarettes were likely to switch to Bidi's safer e-cigarettes.

We will continue to monitor the developments in the Bidi case and assess the implications of the Eleventh Circuit's final decision on the vaping industry.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More